| 摘要 |
The invention relates to antibodies against alpha-enolase I, their pharmaceutical compositions and diagnosis and treatment uses. Particularly, the invention provides polyclonal anti-alpha-enolase I antibodies and monoclonal single-chain variable fragment (scFv) anti-alpha-enolase antibodies, pharmaceutical compositions containing the same and their uses in uses in diagnosis and treatment of cancers, autoimmune disorders, ischemia and bacterial infection.
|
